Skip to content

    NEKTAR THERAPEUTICS (NKTR) stock price & financials

    View NKTR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+147.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $24.12M
    $29.18M
    $10.46M
    $11.18M
    $11.79M
    -51.1%
    $21.81M
    -25.3%
    $10.86M
    +3.8%
    $10.13M
    -9.3%
    Weakening
    Operating Profit
    -$34.34M
    $14.35M
    -$44.53M
    -$36.23M
    -$31.67M
    +7.8%
    -$27.66M
    -292.8%
    -$39.05M
    +12.3%
    -$42.34M
    -16.9%
    Weakening
    Net Profit
    -$37.06M
    $7.26M
    -$50.88M
    -$41.59M
    -$35.52M
    +4.1%
    -$36.08M
    -596.9%
    -$44.90M
    +11.7%
    -$40.62M
    +2.3%
    Weakening
    EPS
    $-2.66
    $-3.62
    $-2.95
    $-1.87
    +29.7%
    $-1.82
    +49.7%
    $-1.23
    +58.3%
    Strengthening
    Other Income
    -$2.70M
    -$7.35M
    -$1.83M
    -$3.17M
    -$3.35M
    -23.9%
    -$7.04M
    +4.2%
    -$4.04M
    -120.1%
    $2.04M
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$37.05M
    $7.00M
    -$46.37M
    -$39.40M
    -$35.02M
    +5.5%
    -$34.70M
    -595.6%
    -$43.09M
    +7.1%
    -$40.30M
    -2.3%
    Weakening
    MarginsOPM
    -142.4%
    49.2%
    -425.8%
    -324.2%
    -268.6%
    -88.7%
    -126.9%
    -358.0%
    -359.6%
    +15.5%
    -417.9%
    -28.9%
    Weakening
    Tax
    -0.0%
    -3.7%
    -0.1%
    0.5%
    0.1%
    -0.1%
    +97.6%
    -0.1%
    -36.4%
    0.0%
    -100.0%
    Weakening
    ReturnsROIC
    1.0%
    -0.2%
    1.3%
    1.1%
    0.9%
    -4.1%
    0.9%
    1.2%
    -11.7%
    1.1%
    -2.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$194.91M$96.36M$198.96M$25.22M$88.23M$35.28M$44.25M$15.12M$39.27M
    Short-Term Investments
    Total Current Assets$1.44B$1.42B$1.14B$795.58M$545.97M$330.70M$261.29M$266.27M$739.40M
    Net PP&E$48.85M$199.84M$186.14M$177.53M$85.89M$36.86M$11.82M$5.00M
    Goodwill$76.50M$76.50M$76.50M$76.50M$76.50M$0
    Intangibles
    Total Assets$2.15B$1.98B$1.54B$1.12B$710.60M$398.03M$303.85M$280.41M$1.10B
    LiabilitiesTotal Current Liabilities$82.00M$353.89M$115.78M$85.20M$68.20M$51.27M$61.40M$53.54M$70.98M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$142.73M$136.37M$125.74M$112.83M$98.52M$82.70M$65.26M$55.85M
    Total Liabilities$432.60M$571.97M$461.47M$437.68M$343.96M$267.05M$243.11M$190.57M$192.01M
    EquityCommon Stock & APIC$17.0K$17.0K$18.0K$19.0K$19.0K$19.0K$1.0K$2.0K$3.0K
    Retained Earnings-$1.42B-$1.86B-$2.31B-$2.83B-$3.20B-$3.48B-$3.60B-$3.76B-$3.85B
    Total Equity$1.72B$1.41B$1.08B$679.51M$366.64M$130.99M$60.74M$89.83M$903.12M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$718.21M-$328.68M-$313.29M-$412.66M-$304.01M-$192.61M-$175.71M-$208.51M-$233.79M
    Cash from Investing-$1.38B$206.89M$496.21M$202.78M$365.83M$139.56M$142.57M-$1.20M-$844.40M
    Cash from Financing$851.97M$23.36M-$80.35M$36.24M$1.51M$30.0K$42.12M$180.57M$1.07B
    SummaryCapital Expenditure-$14.24M-$26.29M-$7.26M-$14.99M-$5.68M-$865.0K-$1.47M-$171.0K-$244.0K
    Free Cash Flow$703.98M-$354.97M-$320.55M-$427.65M-$309.68M-$193.47M-$177.18M-$208.68M-$234.03M
    FCF Margin59.0%-309.7%-209.6%-419.6%-336.4%-214.7%-180.0%-377.8%-428.7%

    Ratios